|
0
|
|
Emergence of a genetically distinct cluster of influenza A(H3N2) viruses within subclade J.2.2 associated with hospitalization during the 2024-2025 season in Auvergne-Rhone-Alpes, France.
(microbiologyresearch.org)
|
Koumaty L
…
Josset L
Microbial Genomics
2026-09-01
|
#influenza
#sequencing
#surveillance
#immune escape
#virulence
|
|
0
|
|
An endonuclease inhibitor unlocks the PA-X shutoff mechanism in influenza A virus.
(linkinghub.elsevier.com)
|
Oishi K
…
Kawaoka Y
Cell Reports
2026-09-01
|
#influenza
#endonuclease
#rna
#shutoff
#virulence
|
|
0
|
|
Emergence and spread of NA-I223V and NA-S247N double-mutant A(H1N1)pdm09 influenza viruses with reduced oseltamivir susceptibility in the Netherlands and beyond, 2023 to 2026.
(eurosurveillance.org)
|
Felix Garza Z
…
Meijer A
Eurosurveillance
2026-09-01
|
#influenza
#surveillance
#antiviral-resistance
#sequencing
#mutation
|
|
0
|
|
Baloxavir marboxil versus oseltamivir for influenza A in children aged 5 years and older: a community-based prospective cohort study.
(link.springer.com)
|
Li W
…
Yan J
BMC Infectious Diseases
2026-09-01
|
#influenza
#antiviral
#pediatrics
#clinical trial
#therapeutics
|
|
0
|
|
Recombinant Influenza Vaccine and Influenza Outbreaks in US Nursing Homes: Results From a Pragmatic Cluster-Randomized Clinical Trial.
(academic.oup.com)
|
McConeghy KW
…
Gravenstein S
Open Forum Infectious Diseases
2026-09-01
|
#vaccination
#influenza
#clinical trial
#outbreak
#elderly
|
|
0
|
|
Identifying a broad-spectrum influenza inhibitor that blocks multiple functions of viral NS1 protein.
(nature.com)
|
Zhang Y
…
Li D
Nature Communications
2026-09-01
|
#influenza
#antiviral
#inhibitor
#virulence
#protein-protein interaction
|